Rebound activation of coagulation after treatment with unfractionated heparin and not with low molecular weight heparin is associated with partial depletion of tissue factor pathway inhibitor and antithrombin

Author： Hansen J.-B.   Naalsund T.   Sandset P.M.   Svensson B.  

Publisher： Elsevier

ISSN： 0049-3848

Source： Thrombosis Research, Vol.100, Iss.5, 2000-12, pp. : 413-417

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Differential Effects of Low Molecular Weight Heparin and Unfractionated Heparin on Circulating Levels of Antithrombin and Tissue Factor Pathway Inhibitor (TFPI) - Insight into its possible mechanism of action

By Hansen J.-B.   Sandset P.M.  

Thrombosis Research, Vol. 91, Iss. 4, 1998-08 ,pp. : 177-181

Elsevier

Access to resources Recommend Favorite

The effect of protamine sulphate on plasma tissue factor pathway inhibitor released by intravenous and subcutaneous unfractionated and low molecular weight heparin in man.

By Holst J.   Lindblad B.   Bergqvist D.   Hedner U.   Nordfang O.   Ostergaard P.  

Thrombosis Research, Vol. 86, Iss. 4, 1997-05 ,pp. : 343-348

Elsevier

Access to resources Recommend Favorite

Markers of hemostatic system activation during treatment of deep vein thrombosis with subcutaneous unfractionated or low-molecular weight heparin

By Peternel P.   Terbizan M.   Tratar G.   Bozic M.   Horvat D.   Salobir B.   Stegnar M.  

Thrombosis Research, Vol. 105, Iss. 3, 2002-02 ,pp. : 241-246

Elsevier

Access to resources Recommend Favorite

TFPI antigen levels in normal human volunteers after intravenous and subcutaneous administration of unfractionated heparin and a low molecular weight heparin

By Hoppensteadt D.A.   Walenga J.M.   Fasanella A.   Jeske W.   Fareed J.  

Thrombosis Research, Vol. 77, Iss. 2, 1995-01 ,pp. : 175-185

Elsevier

Access to resources Recommend Favorite

Reduction of Factor FVIIa Activity During Heparin Therapy - Evidence for Assay Interactions with Tissue Factor Pathway Inhibitor and Antithrombin

By Hansen J.-B.   Svensson B.   Sandset P.M.   Thijssen F.  

Thrombosis Research, Vol. 100, Iss. 5, 2000-12 ,pp. : 389-396

Elsevier

Access to resources Recommend Favorite